A new measurement site for echocardiographic epicardial adipose tissue thickness and its value in predicting metabolic syndrome.
Introduction
Epicardial adipose tissue (EAT) is the visceral thoracic fat depot that surrounds the heart, located between the myocardium and the visceral pericardium. It has been reported that EAT is associated with multiple pathological states, including metabolic syndrome, T2DM, atrial fibrillation, and coronary artery disease. [1] [2] [3] Recent studies have shown that EAT thickness measured with echocardiography may play a limited additional role supporting current risk stratification strategies in identifying individuals at an increased risk of metabolic syndrome. 4, 5 Moreover, measurements of EAT thickness attained by echocardiography and computed tomography (CT) are inconsistent. 6, 7 This fact may be explained by the poor distribution of EAT at the measurement site. Echocardiographic EAT thickness has been defined as the thickness of the low-isoechoic area on the free wall of the right ventricle in the parasternal long-axis and shortaxis views, 8, 9 but the distribution of EAT is unbalanced and is concentrated primarily in the interventricular and atrioventricular grooves rather than in the free wall of the right ventricle. 7 Therefore, there is clinical value in finding a new measurement site for echocardiographic EAT thickness which can better reflect the risk of metabolic syndrome. In addition, Salami et al. have confirmed that there are significant racial differences in the distribution of EAT. 10 A large-sample investigation of EAT thickness in Chinese adults has not yet been published. In this study, a total of 975 Chinese adults were measured for EAT thickness on the right ventricular anterior free wall (EAT-rv) and on the anterior interventricular groove (EAT-ivg). Distribution of EAT and its consistency with epicardial adipose volume (EAV) were described, and its independent association with metabolic syndrome and its value in predicting metabolic syndrome were analyzed. The aims were to explore a new measurement site which can better reflect EAT thickness and to assess its value in predicting metabolic syndrome.
Material and methods

Participants
A total of 986 Chinese adults receiving a general check-up at the Health Management Center of Shandong Provincial Hospital between January 2017 and September 2017 were enrolled in the study. The exclusion criteria consisted of the following: 1) age <18 years or >75 years; 2) atrial fibrillation; 3) serum creatinine level >2 mg/dL; 4) hypothyroidism; 5) current or past use of glucagon-like peptide (GLP)-1, SGLT2 inhibitors, thiazolidinediones, fibrates, statins, or insulins; 6) coronary heart disease; and 7) advanced malignant tumors. Transthoracic 2-dimensional echocardiography was performed in all participants, and 11 participants were excluded because of inadequate image quality. This study was approved by the ethics committee of Shandong Provincial Hospital, China (approval No. 2016024138), and all participants provided their written informed consent.
Measurement of EAT thickness
Transthoracic 2-dimensional echocardiography was performed with a Philips iU22 ultrasound system and an s5-1 matrix-array transducer (Phillips Healthcare, Bothell, USA) according to the recommendations of the European and American Societies of Echocardiography. 11, 12 All participants were placed in the left lateral decubitus position. Ultrasonic images were stored in specialized workstations where EAT thickness was measured by the same reader. According to recommendations by Iacobellis et al., EAT thickness on the right ventricular anterior free wall (EAT-rv) was measured, 8, 9 as shown in Fig. 1 . In addition, EAT thickness on the anterior interventricular groove (EAT-ivg) at the midchordal level and the tip of the papillary muscle from the parasternal short-axis view was measured as a new measurement site, as shown in Fig. 2 . The average value of 3 cardiac cycles for each echocardiographic view was used for analysis.
Quantification of epicardial adipose volume
Among these 975 participants, 120 were randomly selected for cardiac dual-source computer tomography (DSCT). Cardiac DSCT was performed using a 128-slice DSCT scanner (Siemens AG, Munich, Germany). Image reconstructions were performed at 75% RR intervals. A density ranging from −30 to −190 Hounsfield units was employed to identify adipose tissue. The pericardium was manually traced from the right pulmonary artery to the diaphragm in order to determine a region of interest. Epicardial adipose volume was assessed using a dedicated workstation (Syngo.via v. VB10A; Siemens) by the same experienced CT diagnostic physician.
Diagnosis of metabolic syndrome
Metabolic syndrome was determined according to the recommendations of the Chinese Diabetes Society, 13 including: 1) obesity, i.e., body mass index (BMI) ≥25 kg/m 2 ; 2) fasting blood glucose level ≥6.1 mmol/L or the use of antidiabetic medication; 3) triglyceride level ≥1.7 mmol/L; 4) high-density-lipoprotein (HDL) cholesterol count <1.04 mmol/L; and 5) blood pressure higher than 130/85 mm Hg or the use of hypotension medication. Metabolic syndrome was diagnosed when a patient had at least 3 of the above 5 components.
Statistical analysis
All analyses were performed using SPSS software v. 22.0 (IBM Corp., Armonk, USA). Continuous variables with normal distribution were expressed as means ± standard deviations (SDs) and those without normal distribution as 25 th -75 th percentiles (P25-P75). The EAT thicknesses were compared between groups using the Kruskal-Wallis test. Non-conditional logistic regression analysis was performed to determine the association between metabolic syndrome and EAT thickness. The EAV and EAT thickness were grouped according to tertiles, and consistency was determined with κ statistics. Ordered logistic regression was used to identify independent risk factors of EAT thickness (quartiles). The predictive value of EAT thickness was evaluated with a receiver operating characteristic (ROC) curve, and the areas under the curve (AUC) were compared with the Z-test. Significance was set at p < 0.05. 
Results
Distribution of EAT thickness
The mean age of all participants (n = 975) was 55.58 ±11.78 years; their EAT-rv was 3.01 (2.09-3.90) and their EAT-ivg was 5.27 (4.01-6.86). EAT-ivg was greater than EAT-rv (p < 0.05). The distribution of EAT thickness in all participants is shown in Table 1 . Epicardial adipose tissue thickness was higher in older participants and in those with obesity, diabetes, hypertension, hypertriglyceridemia, and metabolic syndrome; it was lower among the male participants. However, EAT-ivg was higher in participants with hypo-high-density-lipoprotein cholesterolemia than in those without this condition, and EAT-rv was not statistically different between the participants with and without hypo-high-density-lipoprotein cholesterolemia.
Consistency between EAT thickness and EAV
The κ value between EAT-rv and EAV was 0.524 (p < 0.05), and that between EAT-ivg and EAV it was 0.783 (p < 0.05) ( Table 2 and 3).
Risk factors of EAT-ivg
As shown in Table 4 , ordered logistic regression analysis showed that advanced age, large waist circumference and female gender were independent risk factors of high EAT-ivg, and HDL cholesterol was a protective factor. On the other hand, BMI, triglyceride, HDL cholesterol, uric acid, creatinine, estimated glomerular filtration rate (eGFR), and Hba1c levels, hypertension, diabetes, and lifestyle (including eating habits, smoking and exercise habit) were not statistically significant.
Association between EAT thickness and metabolic syndrome
As shown in Table 5 , non-conditional logistic regression analysis revealed that EAT-ivg was associated with metabolic syndrome, and the crude, age-adjusted, EAT -epicardial adipose tissue; EAT-rv -EAT thickness on the right ventricular anterior free wall; EAV -epicardial adipose volume. EAT -epicardial adipose tissue; EAT-ivg -EAT thickness on the anterior interventricular groove; EAV -epicardial adipose volume. age-and waist-circumference-adjusted and age-, waistcircumference-and BMI-adjusted odds ratios (ORs) were 1.628, 1.529, 1.363, and 1.331, respectively. The EAT-rv was associated with metabolic syndrome when only age was adjusted for.
Value of EAT thickness applied in predicting metabolic syndrome
As shown in Fig. 3 , the AUC of EAT-rv applied in predicting metabolic syndrome was 0.648 (standard error: 0.018), and the AUC of EAT-ivg was 0.715 (standard error: 0.017). A Z-test showed that the AUC of EAT-ivg was greater than that of EAT-rv (p < 0.05).
Discussion
To our knowledge, this is the first large-scale clinical study to investigate the distribution of EAT and its association with metabolic syndrome. In this study, we explored a new measurement site for echocardiographic EAT thickness (EAT-ivg), which was greater than EAT-rv. The median values for EAT-ivg and EAT-rv were 5.27 (4.01-6.86) and 3.01 (2.09-3.90), respectively. The EAT-rv values found among our sample of the Chinese population were similar to those of South Koreans, 14 but lower than values measured among Caucasians. 15 This racial difference was also confirmed by Fox et al. 16 Our results show that EAT thickness was higher in older people and lower in males, a finding which is consistent with a study by Graeff et al. 4 Both clinical studies and autopsies confirmed that EAT thickness significantly correlates with aging. 15, 17 As for gender difference, our results were consistent with the study by Baragetti et al., 18 but opposite to the study by Calabuig et al. 15 This discrepancy could be explained by the fact that the latter study did not include multivariate analysis.
In 2003, Iacobellis et al. first measured EAT thickness on the right ventricle anterior free wall (EAT-rv) with echocardiography, which showed an excellent agreement with MRI epicardial measurements and a significant association with metabolic syndrome. 8 However, the association was reduced when the size of the study population was increased and multivariate analysis was performed. 4, 15 In our study, EAT-rv also lacked a significant correlation with metabolic syndrome after multivariate analysis, but EAT-ivg did significantly correlate with metabolic syndrome. In addition, the κ value between EAT-rv and EAV was lower than that of EAT-ivg and EAV, and the AUC for the application of EAT-rv in predicting metabolic syndrome was lower than that of EAT-ivg. Therefore, EAT-ivg is a better index for echocardiographic EAT thickness and is more valuable in predicting metabolic syndrome.
We also analyzed the independent risk factors of EAT thickness. In addition to age and sex, waist circumference -a commonly used assessment tool for visceral fat -was also an independent risk factor. This conclusion is consistent with previous reports. 4, 5, 15 High-densitylipoprotein cholesterol is a protective factor of EAT thickness, according to our results. In a cross-sectional study of 72 hemodialysis patients, a low HDL cholesterol level was identified as an independent risk factor of elevated EAT thickness. 19 A meta-analysis showed that there was a highly significant (p < 0.001) correlation between EAT thickness and HDL cholesterol. 5 Our results confirm the previous findings. EAT -epicardial adipose tissue; EAT-rv -EAT thickness on the right ventricular anterior free wall; EAT-ivg -EAT thickness on the anterior interventricular groove; BMI -body mass index; OR -odds ratio. One advantage of this study was employing an echocardiogram to measure EAT thickness in different locations, and then to compare them with EAV as measured with CT. The distribution of EAT thickness was asymmetrical, and the EAT on the anterior interventricular groove was thicker than on the right ventricle anterior free wall. We chose the anterior interventricular groove as the anatomic landmark in the parasternal short-axis view because this landmark was the most definitive and had the maximum distribution of EAT we could find using transthoracic echocardiography. We also compared EAT-rv and EAT-ivg with EAV. Their κ coefficients were small, which was similar to a study by Kim et al., 20 but EAT-ivg had a larger κ coefficient than EAT-rv. This meant that EAT-ivg correlated more strongly with EAV than EAT-rv.
There were also some limitations in our study. Firstly, the participants were people undergoing physical examination, which may have led to selection bias. Secondly, cardiac magnetic resonance is considered the gold standard and it can more accurately assess epicardial fat than transthoracic echocardiography and cardiac DSCT. However, it is expensive and difficult to perform in clinical practice for a large-scale cohort. Thirdly, we did not measure visceral fat because it is also difficult to measure in a large population.
Conclusions
In summary, EAT-ivg had a stronger agreement with EAV than EAT-rv, it was independently associated with metabolic syndrome and it was more valuable in predicting metabolic syndrome than EAT-rv. Therefore, the anterior interventricular groove can serve as a new measurement site which can better reflect EAT thickness.
